EAGLE PHARMACEUTICALS INC shareholders Q3 2023

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Qube Research & Technologies Ltd 17,784$280,4540.00%
Citadel Advisors 292,160$4,607,3630.00%
TWO SIGMA ADVISERS, LP 22,517$355,0930.00%
Citadel Advisors 1,400$22,0780.00%
Citadel Advisors 1,300$20,5010.00%
NORTHERN TRUST CORP 97,247$1,533,5850.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 42,740$674,0100.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Legal & General Group Plc 819$12,9160.00%
GEODE CAPITAL MANAGEMENT, LLC 219,844$3,467,3630.00%
BNP PARIBAS FINANCIAL MARKETS 18,527$292,1710.00%
FARMERS & MERCHANTS INVESTMENTS INC 7$1100.00%
STATE STREET CORP 207,771$3,276,5490.00%
Squarepoint Ops LLC 10,885$171,6560.00%
Glassman Wealth Services 59$9300.00%
RHUMBLINE ADVISERS 17,132$270,1610.00%
NEW YORK STATE COMMON RETIREMENT FUND 6,414$1010.00%
NISA INVESTMENT ADVISORS, LLC 410$6,4660.00%
JPMORGAN CHASE & CO 63,144$995,7810.00%
CWM, LLC 1,064$170.00%
External links

This page lists EAGLE PHARMACEUTICALS INC's shareholders in Q3 2023. To view EAGLE PHARMACEUTICALS INC's shareholder history, click here.